Live Analyst Rating Changes 1525 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Rick Wise
STIF
Rick Wise
Stifel Nicolaus
Wall Street Analyst
★★★☆☆
#1449
on 13Foresight · ranked by our own returns
50%
Success Rate
-1.4%
Average Return
16 of 32 calls profitable · -9.2% vs benchmark
📈 Across the calls we could measure, roughly 50% of Rick Wise's ratings turned a profit when each position was held for 1 year — averaging -1.4% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

108 Buy 22 Hold 0 Sell
Rick's Stock Coverage 30 ratings · 2026-06-20
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return
MDT
Medtronic
 Jun 03, 2026 HOLD Buy
+23.5% avg upside
38 analysts
$80.00
0.74% Upside
 +1.8%
AORT
Artivion
 Jun 01, 2026 BUY Strong Buy
+91.8% avg upside
8 analysts
$45.00
112.46% Upside
 -3.4%
BSX
Boston Scientific
 May 27, 2026 BUY Strong Buy
+72.9% avg upside
38 analysts
$75.00
65.50% Upside
 -10.2%
HTFL
HeartFlow, Inc.
 May 15, 2026 BUY Strong Buy
+9.2% avg upside
8 analysts
$40.00
18.95% Upside
 +8.3%
BDX
Becton Dickinson
 May 08, 2026 BUY Buy
+35.5% avg upside
25 analysts
$175.00
21.54% Upside
 -3.0%
LMAT
Lemaitre Vascular
 May 08, 2026 BUY Strong Buy
+7.8% avg upside
15 analysts
$120.00
27.80% Upside
 -14.7%
MDLN
Medline
 May 08, 2026 BUY Strong Buy
+42.9% avg upside
26 analysts
$50.00
39.22% Upside
 -9.1%
OM
Outset Medical
 May 08, 2026 BUY Buy
+231.0% avg upside
8 analysts
$6.00
18.90% Upside
 -1.9%
TSE:PRN
Profound Medical
 May 08, 2026 BUY Strong Buy
+96.1% avg upside
11 analysts
$14.00
45.72% Upside
 ·
SOLV
Solventum Corporation
 May 06, 2026 BUY Buy
+14.1% avg upside
15 analysts
$90.00
19.30% Upside
 +5.0%
ATRC
Atricure
 May 06, 2026 BUY Strong Buy
+58.1% avg upside
12 analysts
$50.00
73.61% Upside
 +0.4%
SYK
Stryker
 May 01, 2026 BUY Strong Buy
+24.0% avg upside
36 analysts
$360.00
16.97% Upside
 +2.2%
KIDS
OrthoPediatrics
 May 01, 2026 BUY Strong Buy
+59.0% avg upside
10 analysts
$22.00
16.66% Upside
 +14.0%
BAX
Baxter International
 May 01, 2026 HOLD Hold
+49.6% avg upside
23 analysts
$19.00
4.47% Downside
 +21.0%
LUNG
Pulmonx
 Apr 30, 2026 BUY Buy
+321.4% avg upside
9 analysts
$2.50
95.27% Upside
 +7.0%
ZBH
Zimmer Biomet Holdings
 Apr 29, 2026 BUY Buy
+27.6% avg upside
37 analysts
$105.00
19.41% Upside
 +10.8%
GEHC
GE Healthcare Technologies Inc
 Apr 29, 2026 BUY Strong Buy
+36.0% avg upside
20 analysts
$80.00
29.91% Upside
 +3.5%
EW
Edwards Lifesciences
 Apr 24, 2026 BUY Strong Buy
+11.7% avg upside
34 analysts
$110.00
25.96% Upside
 +3.0%
ISRG
Intuitive Surgical
 Apr 22, 2026 BUY Strong Buy
+29.4% avg upside
36 analysts
$670.00
64.66% Upside
 -15.9%
ABT
Abbott Laboratories
 Apr 17, 2026 BUY Strong Buy
+31.2% avg upside
35 analysts
$120.00
35.66% Upside
 -8.7%
JNJ
Johnson & Johnson
 Apr 15, 2026 HOLD Strong Buy
-3.5% avg upside
36 analysts
$250.00
9.41% Upside
 -3.8%
KMTS
Kestra Medical Technologies Ltd.
 Mar 18, 2026 BUY Strong Buy
+37.1% avg upside
7 analysts
$30.00
50.52% Upside
 -2.5%
TMCI
Treace Medical Concepts
 Mar 01, 2026 HOLD Hold
+27.0% avg upside
8 analysts
$3.00
28.41% Downside
 +7.2%
LIVN
LivaNova
 Feb 25, 2026 BUY Strong Buy
+0.2% avg upside
14 analysts
$80.00
1.98% Upside
 -0.4%
AVNS
Avanos Medical
 May 07, 2025 HOLD Buy
+9.6% avg upside
5 analysts
$14.00
43.96% Downside
 +96.9%
CNMD
Conmed
 May 01, 2025 HOLD Hold
+81.2% avg upside
12 analysts
$55.00
68.77% Upside
 -35.2%
VRAYQ
Viewray
 Jun 03, 2023 HOLD Strong Buy
+558333233.4% avg upside
12 analysts
$1.00
99999900.09% Upside
 -100.0%
HIND
Vyome Holdings
 Feb 25, 2019 BUY Strong Buy
+1351.6% avg upside
8 analysts
$30.00
1282.52% Upside
 -91.9%
TNDM
Tandem Diabetes Care
 Aug 22, 2018 HOLD Buy
+116.0% avg upside
29 analysts
$34.00
122.22% Upside
 +77.7%
IDXX
Idexx Laboratories
 Nov 08, 2012 HOLD Buy
+29.2% avg upside
17 analysts
 — +21.9%
🔒 25 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
Rick Wise — Frequently Asked Questions
How accurate are Rick Wise's stock ratings?
Based on the calls 13Foresight could measure, about 55% of Rick's ratings were profitable over a one-year hold, with an average return of +2.1% per rating, or -5.0% versus the S&P 500. We score every analyst the same way, from historical prices.
How is Rick ranked on 13Foresight?
Rick Wise is currently ranked #1449 with a 3-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Rick cover?
Rick most recently has ratings on MDT, AORT, BSX, HTFL, BDX, LMAT, MDLN, OM, TSE:PRN, SOLV, ATRC, SYK and 18 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.